低强度华法林抗凝治疗高出血风险的房颤患者有效性及安全性临床-研究.pdfVIP

  • 8
  • 0
  • 约3.79万字
  • 约 29页
  • 2018-11-24 发布于江苏
  • 举报

低强度华法林抗凝治疗高出血风险的房颤患者有效性及安全性临床-研究.pdf

英文摘要 blood occultblood andrenal function test,urinary test,liver test,blood sugar levels fat the heartcolorwithoutleftatrialthrombosistest. test,bloodtest,and the researchweneedtorecordthe During patient’S diseaseof diseasetimeof the hastakenthe AF,the AF,whether patient antithrombotic or hasthe of or not,whether drugs they history bleeding thrombosisor otherdiseasescombinedwithsuchas any hi醣bloodpressure, diabetesand disease. coronaryartery Theenrolled were Warfarinwithlowmolecular patientstaking2.5mg thefirst3-5 testtheINRdata 2or weightheparin(LMWH)atdays,and every 3 atthefirsttwo thedoseofwarfarinuntiltheINRwas days weeks.Adjust stable totheINRdata.ThentesttheINRdataoncea relativelyaccording monthfor12 theincidenceofstrokeand events months.Observing bleeding ofthetwo resultswere withX2 analyzed test(x土s), groups.The statistically statisticstestedhadmarked by difference,PO.05. Results:Therewere99selected andthedurationof is

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档